Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 M2I ALMII Apr 24, 2025 8.40 +0.89   
 Maat Pharma S.A. MAAT Apr 24, 2025 5.82 -1.69   
 Macompta.FR S.A. MLMCA Apr 24, 2025 6.20 +1.64   
 Made MLMAD Apr 24, 2025 9.95 0.00   
 Magillem Design Services MLMGL Apr 24, 2025 2.00 0.00   
 Maisons du Monde MDM Apr 24, 2025 2.90 -1.19   
 Making Science Group SA ALMKS Apr 24, 2025 9.15 0.00   
 Malteries Franco-Belges MALT Apr 24, 2025 850.00 0.00   
 Manitou BF SA MTU Apr 24, 2025 18.38 +0.55   
 Mare Nostrum ALMAR Apr 24, 2025 0.57 0.00   
 Marie Brizard Wine And Spirits MBWS Apr 24, 2025 3.24 +0.31   
 Maroc Telecom IAM Apr 24, 2025 10.05 +1.52   
 Martifer SGPS SA MAR Apr 24, 2025 1.78 -1.38   
 Mastrad ALMAS Apr 24, 2025 0.02 +7.04   
 Mauna Kea Technologies SA ALMKT Apr 24, 2025 0.09 -1.58   
 Mcphy Energy ALMCP Apr 24, 2025 0.39 +0.64   
 Medesis Pharma S.A. ALMDP Apr 24, 2025 0.35 0.00   
 Media 6 EDI Apr 24, 2025 10.70 0.00   
 Media Lab SpA MLLAB Apr 24, 2025 2.18 0.00   
 Median Technologies ALMDT Apr 24, 2025 2.59 -0.15   
 Medincell S.A. MEDCL Apr 24, 2025 14.95 +1.70   
 Memscap MEMS Apr 24, 2025 3.94 -1.38   
 Mercialys SA MERY Apr 24, 2025 11.54 -0.52   
 Mersen MRN Apr 24, 2025 18.36 +0.88   
 Metavisio S.A ALTHO Apr 24, 2025 0.03 +5.76   
 Methanor ALMET Apr 24, 2025 2.45 +11.02   
 Metropole Television SA MMT Apr 24, 2025 13.84 +0.58   
 Mexedia S.P.A ALMEX Apr 24, 2025 1.20 0.00   
 MG International ALMGI Apr 24, 2025 3.50 0.00   
 MGI Digital Graphic Technology ALMDG Apr 24, 2025 13.24 -2.14   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.